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Abstract 
Traumatic brain injury (TBI) is a critical health problem worldwide, with a high incidence 
rate and potentially severe long-term consequences. Depending on the level of 
mechanical stress, astrocytes react with complex morphological and functional changes 
known as reactive astrogliosis. In cases of severe tissue injury, astrocytes proliferate in 
the area immediately adjacent to the lesion to form the glial scar, which is a major 
barrier to neuronal regeneration in the central nervous system. The flavonoid 
agathisflavone has been shown to have neuroprotective, neurogenic and 
immunomodulatory effects, and could have beneficial effects in situations of TBI.  In this 





astrocytes and neurons to injury, using the in vitro scratch wound model of TBI in 
primary cultures of rat cerebral cortex. In control conditions, the scratch wound induced 
an astroglial injury response, characterized by upregulation of glial fibrillary acidic 
protein (GFAP) and hypertrophy, together with reduction in proportion of neurons within 
the lesion site. Treatment with agathisflavone (1 μM) decreased astroglial GFAP 
expression and hypertrophy and induced an increase in the number of neurons and 
neurite outgrowth into the lesion site. Agathisflavone also induced increased expression 
of the neurotrophic factors NGF and GDNF, which are associated with the 
neuroprotective profile of glial cells. These results demonstrate that in an in vitro model 
of TBI the flavonoid agathisflavone modulates the astrocytic injury response and glial 
scar formation, stimulating neural recomposition. 
Keywords: Flavonoids, agathisflavone, 6,8''-Bisapigenin, NGF, GDNF. 
 
Introduction 
Traumatic brain injury (TBI) is critical health problem worldwide, with a high incidence 
rate and potentially severe long-term consequences (Langlois et al., 2006; Helmy et al., 
2011; Thurman et al., 2016). In addition to the injuries caused directly by trauma, TBI 
has been associated with secondary neurological complications, such as post-traumatic 
stress disorder, memory deficits, chronic neuroinflammation, depression, post-traumatic 
epilepsy and dementia (Simon et al., 2017). The development of drugs that can reduce 
the damage caused by TBI and promote recovery is therefore of great importance 
(Diaz-Arrastia et al., 2014). 
Astrocytes react to injury of the central nervous system (CNS) with complex changes in 
phenotype and function, known as reactive astrogliosis, depending on the severity of 
the stress to which they are subjected. Reactive astrocytes can assume different 
characteristics depending on blood brain barrier disruption, the degeneration of axons 
and local synapses, as well as a possible exposure to pathogens. In turn, reactive 
astrocytes influence neuroinflammatory responses and mechanisms of secondary injury 





morphology and, together with viable neural cells, persist in areas of damaged but 
functional neural tissue. In cases of severe tissue damage, astrocytes proliferate in the 
area immediately adjacent to the lesion and intertwine, forming the glial scar that 
surrounds and restricts the propagation of the intense inflammatory response in the 
center of the lesion (Burda et al, 2016; Costa et. al., 2002; Lefrançois, T. et al., 1997). 
These scar-forming astrocytes are present in areas that contain few or no surviving 
neural cells, interacting primarily with non-neural cells (Wanner et al., 2013). Although 
astrocyte scar formation aids central nervous system axon regeneration after the initial 
damage of the TBI (for review see Anderson et al., 2016), it also interferes with the 
subsequent regeneration of the CNS, inhibiting axonal regeneration (Barreto et al., 
2011). In TBI, reactive astrocytes are characterized by increased expression of vimentin 
and glial fibrillary acidic protein (GFAP), proteins of the intermediate filaments. Knockout 
mice that do not express these proteins demonstrate deficient astrogliosis when 
subjected to TBI, with less removal of cellular debris from the injured area and chronic 
dysfunction of the blood-brain barrier (Pekny et al., 1999), reinforcing the role of 
astrocytes response in TBI. 
There is considerable interest in discovering new drugs that could modulate the 
deleterious effects of TBI-induced astrogliosis and inflammation on the CNS, so that 
they generate beneficial effects (Di Giovanni et al. al., 2005). Similarly, it is also 
important to develop drugs that can stimulate neurogenesis, repopulate the injured area 
with neurons and establish new neuronal connections (Armstrong et al., 2016). 
Flavonoids, which are polyphenolic compounds present in a wide variety of plants, have 
gained prominence as promising therapeutic alternatives for the treatment of CNS 
pathologies such as TBI (Macready et al., 2014), because of their anti-inflammatory 
(García-Lafuente et al., 2009), antioxidant (Zhang et al., 2016) and immunomodulatory 
(Peluso et al., 2015) capabilities. In addition, some flavonoids have proven to be able to 
cross the blood-brain barrier (Wu et al., 2012). One promising compound is the 
biflavonoid agathisflavone, derived from the plant Poincianella pyramidalis Tull, 
botanical synonym for Caesalpinia pyramidalis, popularly known as Catingueira, an 
endemic tree from Northeastern Brazil adopted in popular medicine (Bahia et al., 2005; 





effects, including antiviral (Lin et al., 1997; De Souza et al., 2015a), anti-protozoal (De 
Souza et al., 2015b), anti-inflammatory (Velagapudi et al., 2018) and antitumor (Konan 
et al., 2012, Taiwo et al., 2017). It also induced neuronal differentiation and 
neurogenesis (Paulsen et al., 2011; Dos Santos Souza et al., 2018), as well as 
neuroprotection against glutamate-induced excitotoxicity (Dos Santos Souza et al., 
2018; for a review see Amorim et al., 2018). In this context, the present study 
investigated the effect of the flavonoid agathisflavone on the modulation of the astroglial 
response and integrity of neurons in an in vitro model of TBI. 
 
Methods 
Cerebral Cortex Primary Cultures 
Cell cultures were prepared from the cerebral cortex of Wistar rat embryos, obtained 
from the Center for Laboratory Animal Breeding of the School of Veterinary Medicine 
and Zootechnology of the Federal University of Bahia (Salvador, BA, Brazil). All 
experiments were performed in accordance with the local Ethical Committee for Animal 
Experimentation of the Health Sciences Institute (protocol Nº 027/2012). Cerebral 
Cortex Primary Cultures were prepared from E17/18 wild-type FVB/N mouse embryos 
according with protocols of Weber et al. (2012), with adaptations. The females were 
euthanized in a CO2 chamber and the gravid uteri were removed and placed in a Petri 
dish containing DMEM/HAM-F12 medium (GIBCO: REF 12500-039) supplemented with 
HEPES (3.6 g/L), 50% glucose (100 IU/mL), streptomycin (100 μg/mL) and sodium 
bicarbonate (2.438 g/L). The embryos were removed from the uterus, transferred to 
another plate containing the same medium and decapitated. The cerebral cortices were 
isolated and their meninges were mechanically removed. The cortices were then 
mechanically dissociated with a Pasteur pipette and the cell suspension was gently 
forced through a sterile 75-μm Nitex Cell Strainer (Falcon, Brand-352360). Afterwards, 
the cells were centrifuged for 5 min at 1,000×g, the supernatant was discarded, and the 
cells were resuspended in fresh medium and counted in a Neubauer's Chamber. For 
experiments, cortical cells were resuspended in the abovementioned medium 





culture plates of 24 wells or 60 mm in diameter (TPP, Trasadingen, Switzerland) pre-
coated with Poly-L-ornithine 50 μg/mL (Sigma-ref: P3655), at a density of 2x105 
cells/cm² and cultured for 10 days in a humidified atmosphere with 5% CO2 and 37ºC. 
The medium of cortical cells cultures was changed every two days, and cells were 
cultured for 10 days (Fig. 1). At the time of experiments cortical cell cultures were 
composed of approximately 13% neurons and 67% astrocytes as determined by 
immunocytochemistry as described below. Three independent experiments were carried 
out for the different analysis. 
 
Flavonoid, scratch-wound and treatments 
Agathisflavone was extracted from the aqueous extract of the leaves of P. pyramidalis 
Tull as previously described (Mendes et al., 2000; Bahia et al., 2005; Bahia et al 2010). 
Briefly, fresh leaves (2.2 kg) of P. pyramidalis was extracted with methanol and 
chromatographed using silica gel to afford an enriched fraction of agathisflavone. Four 
grams of biflavonoid were isolated from fractions eluted with ethyl acetate: methanol 
(8:2) and recrystallized from methanol: hexane (1:1). The biflavonoid and its purity was 
carried on by 13C NMR, MS,  and comparison with literature data [1, 2]. The a purity 
grade > 99.5% w/w as determined by DAD HPLC analysis at two wavelengths (254 and 
283 nm)  and the relation of peak/noise of NMR spectra. Agathisflavone (FAB). Pale 
yellow power; m.p. 310-311 oC. APCIMS m/z 537.6 (negative mode); 13C NMR [75 
MHz, (CD3)2CO, d (ppm)]: 163.9 (C-2), 103.3 (C-3), 182.3 (C-4), 159.7 (C-5), 103.6 (C-
6), 163.7 (C-7), 94.1 (C-8), 157.0 (C-9), 103.8 (C-10), 121.5 (C-1'), 128.6 (C-2'), 116.3 
(C-3'), 161.3 (C-4'), 116.3 (C-5'), 128.6 (C-6'), 163.8 (C-2''), 102.7 (C-3''), 181.8 (C-4''), 
160.6 (C-5''), 99.2 (C-6''), 163.6 (C-7''), 99.9 (C-8''), 155.1 (C-9''), 104.1 (C-10''), 121.6 
(C-1'''), 128.2 (C-2'''), 116.2 (C-3'''), 161.2 (C-4'''), 116.2 (C-5''') and 128.2 (C-6'''). 
 
The isolated flavonoid was diluted in dimethyl sulfoxide (DMSO, Sigma) in stock 
solutions of 100 mM that were stored protected from light at -4° C. Final concentrations 





direct dilution of the flavonoid in the culture medium. For the experiments, cultures were 
pre-treated (1 h before injury) with DMSO 0.01% (control) or with agathisflavone (0.1 
and/or 1 μM). Then, they were submitted to a mechanical lesion consisting of a 15-mm 
trace made with a sterile polystyrene tip of 200-μL capacity. After 48 h, the cells were 
processed for immunocytochemical labeling of glia and neuron cytoskeletal proteins, 
western blot and gene expression analysis. 
 
Cell population analysis, neuronal integrity and glial response 
Neuronal integrity and glial response were assessed by immunocytochemical labeling 
for the β- tubulin III (β-TubIII), structural marker of neurons; for the glial fibrillary acidic 
protein (GFAP), structural marker of astrocytes. For both, cells were seeded in 24-well 
plates with glass coverslips previously treated with poly-L-ornithine (50 μg/mL). After 
treatments, the cultures were washed three times with PBS at pH 7.4 and fixed with 4% 
buffered paraformaldehyde for 20 min at 24° C. Excess of paraformaldehyde was 
discarded and the plates were washed three times with PBS. At the time of the 
immunocytochemistry labeling, the cells were permeabilized with PBS/Triton X-100 
(0.2%) and blocked with bovine serum albumin BSA (5%) in PBS for 1 h. The cultures 
were then incubated separately for 12 h in a humid chamber at 4° C with PBS/BSA (1%) 
solution containing mouse monoclonal antibodies specific for β-TubIII (1:500, Abcam - 
AB78078), and rabbit polyclonal antibodies specific for GFAP (1: 500, Wako - G9269). 
After the incubation time, the excess of primary antibodies was removed, the cultures 
were washed three times with PBS and then incubated with goat secondary antibodies 
for rabbit IgGs or mouse IgGs conjugated with Alexa Fluor 488 or Alexa Fluor 594, 
diluted in 1% PBS/BSA (1:1,000), and kept under slow agitation for 2 h at 24° C. Next, 
for the detection of nuclear chromatin, the cultures were stained with the fluorescent 
DNA intercalating agent 4',6-diamidino-2-phenilindol dihydrochloride (DAPI, Molecular 
Probes, Eugene, OR) in a concentration of 5 μg/mL, for 10 min at 24° C. After that, the 
cultures were washed three times in PBS and mounted on slides with N-propyl gallate, 
and then observed under a Leica DM IL LED fluorescence microscope, with a suitable 





independent cultures. For cell counts in the lesion site, eight representative fields were 
photographed at 20x magnification, and the area of the lesion was reconstituted from 
one edge to the other of the lesion. Images were captured with either a 40x objective or 
a 63x oil immersion objective using a Leica TCS SP8 Spectral Confocal Microscope for 
more detailed photos. All experiments included cultures where the primary antibodies 
were not added, unspecific staining was not observed in such negative controls.  
 
RNA extraction and qPCR 
Total RNA was isolated from embryonic cerebral cortex cell cultures with the Trizol 
reagent (Ambiom 15596018) according to the manufacturer's specifications. For that, 
7x104 cells/cm2 were grown in 60-mm plates and treated; the samples were stored at -
80° C until the time of the analysis. Both the concentration and the purity of the RNA 
were determined with spectrophotometric analysis using the Kasvi nanospectrum (K23-
0002). DNA contaminants were removed with the treatment of DNase RNA samples 
using the Ambion DNA-free kit cat # AM1906 (Life Technologies™). For cDNA 
synthesis, VILO™ cat # MAN0004286 (Invitrogen, Life Technologies™) Master Mix 
Super Script® was used in a 20-μL reaction with a concentration of up to 2.5 μg of total 
RNA. Real-time quantitative PCR was performed using Taqman® Gene Expression 
Assays (Applied Biosystems, CA, USA) containing two primers to amplify the Taqman® 
MGB and Taqman® MGB specific probe sequence and TaqMan® Universal Master Mix 
II with UNG (Catalog # 4440038 Invitrogen, Life Technologies™). Assays for the genes 
quantified in this study were: NGF (Rn01533872_m1) and GDNF (Rn00569510_m1). 
Real-time PCR was performed using the QuantStudio™ 7 Flex Real-Time PCR System 
(Applied Biosystems, CA, USA). The thermocycling conditions were performed 
according to the manufacturer's specifications. The β-actin target (Rn00667869_m1) 
was used as the reference gene (endogenous control) for normalizing gene expression 
data. The analysis of real-time polymerase chain reaction data was based on 
Schmittgen and Livak (2008), using the 2-ΔΔCt method. Tests were performed in 
triplicate in different plates of each cDNA using different samples were analyzed and 







After treatment, cultures of embryonic cortex were collected, lysis buffer (4 M urea, 2% 
SDS, 2 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA), 
62.5 mM Tris-HCl pH 6.8, 2 mM ethylenediaminetetraacetic acid (EDTA), 0.5% Triton X-
100) supplemented with protease inhibitor cocktail (Sigma-Aldrich, P8340) was added 
and the total proteins were extracted. Five micrograms of protein per column were 
separated by electrophoresis on 12% polyacrylamide gel. After separation, the proteins 
were transferred to a polyvinylidene fluoride (PVDF) membrane (Hybond, Amersham, 
Piscataway, USA) in a semi-dry system (Bio-Rad, Hercules, USA) for 120 min at a 
constant current of 0.15 mA. The membranes were blocked with 5% skimmed milk 
diluted in Tris-buffered saline (TBS) containing 0.05% Tween-20 (TBS-T) at room 
temperature under stirring. After blocking, the membranes were incubated with anti-
GFAP (rabbit, 1: 1,000, DAKO Z0334) or anti-β-actin (rabbit, 1: 5,000, Sigma A5060) 
primary antibody overnight at 4° C. The membranes were then washed three times with 
TBS-T and incubated for 1 h at room temperature on shaking with peroxidase-
conjugated goat anti-rabbit secondary antibody (1: 5000; Molecular probes, G21234) 
diluted in TBS- T 5% skimmed milk. After three washes with TBS-T and one wash with 
TBS, the membranes were incubated with the chemiluminescent reagents (ECL Plus 
substrate kit Biorad) for 5 min. The blots were then analyzed by the ImageQuant LAS 
500 apparatus (GE Healthcare Life Sciences). The value of each protein was 
normalized according to the amount of β-actin in the same sample. Quantification was 
obtained by scanning densitometry (ScanJet 4C, Hewlett Packard) of three independent 
experiments, and analyzed with ImageJ 1.33u software (Wayne Rasband, National 
Institutes of Health, USA).  
 
Statistical analyses 
Statistical analyses were performed using the GraphPad Prism 5.0 software (San 





variance (ANOVA) when more than 2 groups were compared, followed by Student's 
Newmann-Keuls' post-test. The results were expressed as the mean ± standard 




Analysis of neuron integrity and astrocyte response 
Figure 1 illustrates embryonic cortical cultures 48 h after a scratch wound under phase 
contrast microscopy. In control culture conditions (normal medium plus the drug vehicle 
0.01% DMSO), cells are observed to extend few projections from the border of the 
lesion site and few cells are present within the lesion. In contrast, cultures treated with 
agathisflavone (1 μM) displayed an increased number of cellular projections into the 
lesion site and a much larger number of cells in the lesioned area. 
 
Figure 1 - Effect of the pre-treatment with agathisflavone (FAB) on the migration 
of cells and extension of projections to the site of mechanical injury in primary 
culture of embryonic cerebral cortex of rats. Phase contrast photomicrographies of 
cultures maintained in control conditions (0.01% DMSO, A) or treated for 1 h with 1 μM 
agathisflavone (B), submitted to injury and analyzed after 48 h. Obj. 10x. Scale bar 200 






In order to characterize the glial and neuron cell profile in the lesion site under control 
conditions and after treatment with agathisflavone, two cytoskeletal markers were used, 
GFAP for astrocytes and β-tubulin III (β-TubIII) for neurons in the cortical cultures, 
characterized of about 13% neurons and 67% astrocytes; nuclei of the cells were 
stained with DAPI, a nuclear chromatin intercalating agent (Fig. 2). In controls, injury 
induced astrogliosis, with increase of astrocyte processes associated with increased 
expression of GFAP, especially visible at the edges of the lesions, together with a 
reduction of neurites at the edge of the lesion, with decreased expression of β-TubIII. In 
the culture treated with agathisflavone (1 μM), there was modulation of the astrocytic 
response, with a decrease of GFAP in astrocytic processes that invade the area of the 
lesion from the border, which are less thick, as well as an increase in neurons within the 
lesion and the growth of neurites that enter the lesion. It was possible to observe that 
neurite migrated along astrocytic bodies in the lesion zone, leading to the other edge of 






Figure 2 - Effect of the flavonoid agathisflavone (FAB) on the morphology and 
migratory behavior of neurons and astrocytes in primary culture of embryonic 
cerebral cortex of rats submitted to mechanical injury. Cultures were maintained in 
control conditions (0.01% DMSO) or treated for 1 h with 1 μM agathisflavone, submitted 
to injury and analyzed by Immunocytochemistry for GFAP (red) and β-tubulin III (β-
tubIII, Green); nuclei were stained with DAPI (Blue). Confocal photomicrographies of 
GFAP positive astrocyte and β-tubIII positive neurons in the edge of the lesions; dashed 
lines indicate the edges of the lesions; Obj. 40x. Scale bar 50 μm. In lesioned cultures, 
reactive astrocytes with increased GFAP expression can be seen at the border of the 
lesion, as well as lesioned neurites (white arrows). Treatment with agathisflavone 
modulated the astrocytic response, with astrocytic processes invading the area of the 






Quantification of cells that migrated to the lesion site revealed that in cultures treated 
with agathisflavone (1 μM), there was a significant increase in the number of nuclei 
stained with DAPI in the lesioned area (104.1 ± 8.008) when compared to the control 
(DMSO 0.01%) (38 ± 6.728), indicating that flavonoid induced cells to migrate to the 
lesioned area (Fig. 3A). Treatment with agathisflavone also resulted in a significant 
increase in β-TubIII positive neurons (β-TubIII+) in the lesion, from 1.03 ± 0.67 to 16.68 
± 1.30% (Fig. 3B), whereas GFAP+ astrocytes were significantly reduced in the lesioned 
area, from 18.67 ± 0.82% to 0.55 ± 0.61% (Fig. 3C), as were the number of GFAP+ 






Figure 3 - Analysis of the effect of the flavonoid agathisflavone on the 
morphology and migratory behavior of astrocytes and neurons in primary culture 
derived from the embryonic cortex of rats submitted to mechanical injury. (A) 
Number of nuclei stained with DAPI in the lesioned area. (B) Percentage of β- tubulin III 
(β-tubIII) labeled cells in the lesioned area. (C) Percentage of GFAP-labeled cells 
(GFAP+) in the lesioned area. (D) Number of GFAP+ hypertrophic processes at the 
edge of the lesion. T- Test * P <0.05. 
 
In order to quantify changes in GFAP expression levels, western blot for GFAP was 
performed 48 h after scratch wound. Treatment with agathisflavone at 1 μM, which 
induced the morphological effects described above, induced a significant reduction in 
GFAP expression (72.74 ± 4.78%), when compared to the control (considered 100%) 
(Fig. 4); 0.1 μM agathisflavone had no effect on GFAP expression compared to the 
control cultures. 
 
Figure 4 - Effect of the flavonoid agathisflavone (FAB) on the expression of glial 
fibrillary acidic protein (GFAP) in primary culture of embryonic cerebral cortex of 
rats subjected to mechanical injury. Cultures were maintained in control conditions 





analyzed after 48 h. (A) Western blot analysis for GFAP and β-actin. (B) Densitometry 
analysis of the ratio of GFAP/β-actin expression; values expressed as mean ± standard 
deviation and control was considered as 100%; results were analyzed by One-way 
ANOVA followed by followed by Student's Newmann-Keuls' post-test; * P≤0.05. 
Experiment showed a decrease in GFAP expression in cultures treated with 1μM FAB 
and submitted to scratch injury, compared to control cultures.  
 
 
Effect of the treatment with the flavonoid agathisflavone on expression of 
neurotrophic factors  
To investigate the molecular mechanisms that could be involved in the observed effects 
of agathisflavone on increasing neurons and neurite outgrowth within the scratch lesion, 
we examined mRNA expression for the neurotrophins NGF and GDNF, using RT-qPCR 
(Fig. 5). In non-lesioned cultures, compared to non-lesioned control cultures, 
agathisflavone at the effective concentration of 1 μM induced a 3.6-fold and 6.3-fold 
increase in NGF and GDNF mRNA expression, respectively. In contrast, 0.1 μM 
agathisflavone induced a 2.4-fold increase in NGF mRNA expression and reduction of 
GDNF mRNA expression. Following scratch wound, compared to untreated control 
cultures, agathisflavone at the effective concentration of 1 μM induced a 25-fold and 
8.3-fold increase of mRNA expression of NGF and GDNF, respectively. At 0.1 μM, 
agathisflavone induced a 2.5-fold increase in NGF and GDNF mRNA expression. When 
lesioned and non-lesioned cultures under control conditions (DMSO 0.01%) were 
compared, no difference between the levels of mRNA expression was observed for the 






Figure 5 - Effect of the flavonoid agathisflavone on the expression of 
neurotrophic factors in primary culture of embryonic cerebral cortex of rats 
submitted or not to mechanical injury. Cultures were maintained in control conditions 
(0.01% DMSO) or treated for 1 h with 1 μM agathisflavone, injured and analyzed after 
48 h. Expression of mRNA for neurotrophic factors NGF and GFDN was analyzed with 
RT-qPCR;  NL = Non-lesioned; L = Lesioned; values expressed as mean ± standard 
deviation; significant differences are expressed as * P≤0.05 when compared to the 
control NL; # P≤0.05 when compared to FAB 0.1μM NL treatment; & P≤0.05 when 
compared to the Control L; and §P≤0.05 when compared to FAB 0.1μM L treatment. 
One-way ANOVA followed by Student's Newmann-Keuls' post-test. Agathisflavone 
increased the expression of GDNF and NGF in a dose-dependent manner in cultures 




In vitro models for CNS injury are an important step in the development of new 
neuroprotective therapies. The model of mixed culture of cells from the embryonic 
cortex forms a confluent monolayer of glial cells that adheres to the plaque and allows 
the development of morphologically mature neurons on glia (Weber et al., 2012). In 





(Han et al., 2014), which allows the evaluation of the effects of drugs such as the 
flavonoid agathisflavone on modulation of the astrocyte injury response and scar 
formation, integrity of neurons and restoration of neuronal projections. Although this 
flavonoid has already been tested for some pharmacological effects, such as increased 
induction of neurogenesis in association with retinoic acid (Paulsen et al., 2011), affinity 
for GABAergic receptors (Grosso et al., 2013) and neuroprotection (Dos Santos Souza 
et al. al., 2018), there is nothing on its effects on TBI models in the literature. Together, 
the results of this study show that the flavonoid agathisflavone modulates the astrocytic 
injury response and formation of glial scar, favoring the migration of neurons to the site 
of the lesion neurite outgrowth. These effects were associated with stimulation of NGF 
and GDNF, neurotrophins that are important for neuronal outgrowth.  
Consistent with previous studies, we observed that the scratch wound caused a typical 
astrocyte injury response, with upregulation of GFAP and cellular hypertrophy at the 
lesion edge, similar to scar formation. Shi et al. (2015) observed morphological changes 
in GFAP expression by astrocytes in cultures after mechanical injury, with these cells 
having extended astrocytic processes to the cell-free area 12 h post-injury, which were 
shown to be more prominent after 24 h. A similar behavior was also seen by Huang et 
al., (2009), with processes extending to the area of the injury 24 h after trauma. Katano 
et al. (1999) performed a mechanical lesion on astrocyte cultures and on glial and 
neuronal co-cultures and noted that the migration and extension of astrocyte projections 
after 24 h was much more intense in cultures with only glial cells compared to co-
cultures. In both cultures, astrogliosis was observed at the edges of the lesion, 
characterized by increased GFAP expression and astrocyte morphology change. Costa 
et al. (2002) reported that after mechanical injury, glia and neuronal co-cultures exhibit 
reactive and hypertrophic astrocytes at the edge of the lesion, forming a poorly 
permissive environment for neuronal migration or neurite outgrowth. They also reported 
that, by decreasing GFAP expression of injured astrocytes through the treatment with 
antisense GFAP-mRNA and association with the extracellular laminin matrix 
component, there was a decrease in astrocytic reactivity and a return of neuron 
migration and neurite outgrowth to the area of the lesion. The same profile of astrocytic 





of GFAP after mechanical lesion, was observed in the present study, with the 
establishment of a glial scar that was not permissive for the migration of neurons or 
neurites to the lesioned area. Significantly, treatment with agathisflavone (1 μM) led to a 
decrease in GFAP expression and astroglial scar formation, associated with increased 
neurite outgrowth towards the injured area and neuronal repopulation of the lesion site. 
Previous studies on neural cell cultures (astrocytes, neurons and oligodendrocytes) 
derived from neural stem cells and subjected to mechanical injury (Lööv et al., 2012; 
2013) observed that the neurons were attracted and migrate to the site of lesion in the 
process of regeneration, but they did not cross the edges of the lesion. Astrocytes were 
also attracted to the site of lesion, extending their processes beyond the edges towards 
the cell-free area. Surgucheva et al. (2014), in the same type of culture, also submitted 
to mechanical injury, reported a change in the morphology of the neurons next to the 
lesion, with loss of axons and fewer neurites, as well as the migration of a small number 
of neurons to the interior of the lesion after 48 h. It was also shown that astrocytes 
extend their processes and migrate to the area of the lesion. Similar characteristics 
were observed in the present study, where control cultures presented the rupture and 
loss of neurites and axons in the lesioned area after 48 h, and the migration of a small 
number of neurons that migrated into the lesion, associated with astrocytes that 
migrated and extended its hypertrophic processes to the injured area. However, in the 
cultures that were treated with the flavonoid agathisflavone and injured, modulation of 
the astrocyte response was observed, with decreased expression of GFAP and 
astrocytes with less reactive morphology, making the glial scar more permissive for 
migration and growth of neurons.  
The effects of agathisflavone increasing the number of neuron bodies in the edge of the 
lesion and the neurons penetrating the lesioned area observed in this study were 
associated with the increase of NGF and GDNF. Neurons and glial cells secrete 
endogenous peptides called neurotrophins, which are important for the regulation of 
synaptic plasticity, the stimulation of neurogenesis and the protection of neurons against 
apoptosis (Kuipers et al., 2016; Wurzelmann et al., 2017). NGF is essential for the 





far from its site of action and transported to neurons where it will promote survival, 
functional and developmental changes in these cells (Lane et al., 2014; Li et al., 2018). 
GDNF is known for its important role in neuronal survival and stimulus for axon growth, 
in addition to being associated with neuroprotection against metabolic and excitotoxic 
insults (Bankston et al., 2013; Cohen et al., 2011; Nagahara et al., 2009). In a previous 
study, developed in co-cultures of murine neurons and glia submitted to glutamate 
excitotoxicity, we demonstrated that agathisflavone was able to increase the expression 
of several neurotrophins, among them BDNF, NGF, CDNF, NT4 and GDNF. This 
increase in the expression of neurotrophins was associated with neuroprotection 
against glutamate excitotoxicity (Dos Santos Souza et al., 2018). Some of the important 
aspects in the pathology of the TBI are excitotoxicity by glutamate, the loss of neurons 
and neuronal extensions, as well as the formation of a glial scar that interferes in the 
regeneration of the CNS (Barretto et al., 2011; Johnson et al., 2013; Rosenfeld et al. al., 
2012). Moreover, Paulsen et al. (2011) reported that, when used in combination with 
retinoic acid (RA) in embryonic stem cells and murine-induced pluripotent stem cells, 
agathisflavone increases RA-induced neuronal differentiation 2-fold or more in both cell 
types. Therefore, a drug such as agathisflavone, capable of interfering beneficially in all 
these aspects, is of great importance.  
Phytoestrogens are compounds of plant origin that can mimic, structurally or 
functionally, mammalian estrogen. One example is the isoflavone genistein, whose 
activation of estrogen receptors is one of the mechanisms responsible for its 
osteoblastogenic effects (Cepeda et al., 2020). Another is apigenin, the monomer that 
forms agathisflavone, which is described as pro-estrogenic and acts as a phytoestrogen 
and / or estrogen receptor modulator (Zand et al., 2000). Agathisflavone itself has also 
been described as a phytoestrogen and its pro-neuronal effects are at least partially 
mediated by the activation of the estrogen receptors α and β (Dos Santos Souza et al., 
2018). Steroid hormones, including estrogen, can influence the development and 
function of the nervous system, affecting areas such as synaptic plasticity (Takeuchi et 
al., 2015) and cognitive function (Luine et al., 2014), as well as providing 
neuroprotective effects (Engler-Chiurazzi et al., 2016). However, the use of estrogen-





cardiovascular problems. A possible solution would be to use substances that 
specifically modulate estrogen receptors to achieve the beneficial effects without the 
associated risks (Su et al., 2018) and it has been reported that agathisflavone interferes 
with neurogenesis and neuronal differentiation through the activation of estrogen 
receptors (ERα and ERβ) (Dos Santos Souza et al., 2018). Moreover, toxicological 
evaluation of the biflavonoid agathisflavone showed LD50 larger than 2000 mg/kg and 
that it did not change significantly the hematological, biochemical, histopathological, 
behavioral, as well as physiological parameters in mice (Andrade et al., 2018). In this 
sense, agathisflavone could be a potential candidate as a phytoestrogen drug to 
attenuate astrogliosis and reestablish the population of neurons and neuronal 
connections in brain lesions such as TBI. 
 
Conclusion 
Our findings demonstrate that the flavonoid agathisflavone is capable of modulating 
astrocytic response and glial scar formation, while also stimulating neural network 
recomposition in an in vitro model of TBI, associated with the modulation of GDNF and 
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